Search results for "Carcinoma"

showing 10 items of 3529 documents

The impact of radiotherapy on survival in resectable gastric carcinoma: A meta-analysis of literature data.

2007

Summary Background The benefit of external radiotherapy for gastric carcinoma has been extensively studied, but data on survival are still equivocal. Objective To assess the effectiveness of surgery combined with preoperative radiotherapy or postoperative chemoradiotherapy in the reduction of all-cause mortality in patients with resectable gastric carcinoma. Methods Computerised bibliographic searches of MEDLINE and CANCERLIT (1970–2006) were supplemented with hand searches of reference lists. Study selection Studies were included if they were randomised controlled trials (RCTs) comparing mortality of surgery combined with preoperative radiotherapy or postoperative chemoradiotherapy to surg…

medicine.medical_specialtySurvivalmedicine.medical_treatmentGastric carcinoma; Meta-analysis; Radiotherapy; SurvivalMEDLINElaw.inventionRandomized controlled triallawStomach NeoplasmsGastric carcinoma; Meta-analysis; Radiotherapy; Survival;medicineCombined Modality TherapyHumansRadiology Nuclear Medicine and imagingMeta-analysiRandomized Controlled Trials as TopicIntention-to-treat analysisRadiotherapybusiness.industryMortality rateGastric carcinomaGeneral MedicineCombined Modality TherapySurgeryRadiation therapyOncologyMeta-analysisRadiotherapy AdjuvantbusinessChemoradiotherapy
researchProduct

Expression of differentiation antigens and growth-related genes in normal kidney, autosomal dominant polycystic kidney disease, and renal cell carcin…

1992

Cellular differentiation and mRNA levels of genes involved in kidney growth were investigated in normal kidney cells, cyst-lining epithelial cells of polycystic kidney disease, and renal carcinoma cells (RCC). All cells comparatively studied exhibited an antigenic phenotype of proximal tubular cells as shown by the expression of a panel of brush border membrane enzymes and kidney-associated cell surface antigens. The epithelial developmental antigen Exo-1 was expressed in 50% to 80% of cyst-lining epithelia in polycystic kidney tissue and in 20% to 30% of polycystic kidney cells cultured in vitro. Normal kidney cells and RCC were negative under identical culture conditions. The expression o…

medicine.medical_specialtyTGF alphaCellular differentiationAutosomal dominant polycystic kidney diseaseGene ExpressionBiologyKidneyEpitheliumProto-Oncogene Proteins c-mycGrowth factor receptorEpidermal growth factorInternal medicinemedicinePolycystic kidney diseaseHumansRNA MessengerGrowth SubstancesCarcinoma Renal CellCells CulturedKidneyurogenital systemAntibodies MonoclonalTransforming Growth Factor alphamedicine.diseasePolycystic Kidney Autosomal DominantAntigens DifferentiationImmunohistochemistryKidney NeoplasmsErbB ReceptorsEndocrinologymedicine.anatomical_structureGenesNephrologyAntigens SurfaceCancer researchTransforming growth factorAmerican journal of kidney diseases : the official journal of the National Kidney Foundation
researchProduct

Brief S2k guidelines - Cutaneous squamous cell carcinoma

2013

medicine.medical_specialtyText miningCutaneous squamous cell carcinomabusiness.industryMEDLINECarcinomaMedicineDermatologybusinessmedicine.diseaseDermatologyJDDG: Journal der Deutschen Dermatologischen Gesellschaft
researchProduct

Endometrial carcinoma and its precursors: Early detection and treatment

1990

Endometrial carcinoma is the most frequent genital neoplasia in women. Precursors of this condition include endometrial hyperplasia, particularly when cytologic atypia occurs. Among the frequent early clinical manifestations of endometrial carcinoma is abnormal uterine bleeding that must be differentiated from bleeding associated with benign conditions. Early detection of endometrial carcinoma and its precursors in women at risk is the best prophylactic measure in the final therapeutic outcome. In this review, the accuracy of methods of early diagnosis of endometrial carcinoma and its precursors is assessed, in order to provide early therapy and optimum prognosis. The epidemiology of endome…

medicine.medical_specialtyTime FactorsBiopsyHysteroscopyEarly TherapyEndometriumDilatation and CurettageRisk FactorsmedicineCarcinomaHumansUltrasonographyGynecologymedicine.diagnostic_testEpitheliomabusiness.industryObstetrics and GynecologyGeneral MedicineHyperplasiamedicine.diseaseEndometrial hyperplasiaEndoscopymedicine.anatomical_structureHysteroscopyEndometrial HyperplasiaUterine NeoplasmsFemalebusinessInternational Journal of Gynecology & Obstetrics
researchProduct

Removal of primary tumor improves survival in metastatic breast cancer. Does timing of surgery influence outcomes?

2010

Resection of intact primary tumor is controversial in metastatic breast cancer patients. The aim of this study is to review the impact of surgical resection of primary tumor on overall survival and to assess the role of timing of surgery on survival rates.208 patients with metastatic breast cancer diagnosed between 1982 and 2005 in the Hospital Clinico of Valencia (Spain) were analysed. Exclusion criteria were age80, PS 3-4, Charlson score 3 or follow-up90 days. 123 of these underwent surgery and 85 did not. In order to assess the role of timing, the "surgery" cohort was divided into two sub-groups: "before" (n = 78) or "after" (n = 45) diagnosis of disseminated disease.In the surgery group…

medicine.medical_specialtyTime FactorsBreast surgerymedicine.medical_treatmentBreast NeoplasmsmedicineHumansNeoplasm MetastasisMastectomySurvival analysisNeoplasm StagingRetrospective StudiesUnivariate analysisPerformance statusbusiness.industryCarcinoma Ductal BreastGeneral MedicineMiddle Agedmedicine.diseaseDebulkingSurvival AnalysisPrimary tumorMetastatic breast cancerSurgeryCarcinoma LobularTreatment OutcomeSpainFemaleSurgerybusinessMastectomyThe Breast
researchProduct

Long-Segment Early Squamous Cell Carcinoma of the Proximal Esophagus: Curative Treatment and Long-Term Follow-Up after 5-Aminolevulinic Acid (5-ALA)-…

2006

Photodynamic therapy (PDT) is an established treatment for the ablation of dysplastic Barrett's epithelium and early esophageal carcinoma, but no data have been published on curative 5-aminolevulinic acid (5-ALA)-PDT for long-segment early esophageal cancer with infiltration of the upper sphincter. We describe successful curative treatment of an unusual early long-segment squamous cell carcinoma (uT1a,N0) of the proximal esophagus (18 - 28 cm aborally), with three sessions of 5-ALA-PDT. Endoscopic and endosonographic follow-up macroscopically showed a complete remission of the tumor, proven by biopsy showing total histological ablation. After a follow-up period of 23 months, there has been …

medicine.medical_specialtyTime FactorsEsophageal NeoplasmsBiopsymedicine.medical_treatmentPhotodynamic therapyGastroenterologyDisease-Free SurvivalEndoscopy GastrointestinalInternal medicineBiopsymedicineCarcinomaHumansEsophagusPhotosensitizing Agentsmedicine.diagnostic_testbusiness.industryGastroenterologyAminolevulinic AcidMiddle AgedEsophageal cancerAblationmedicine.diseaseEndoscopymedicine.anatomical_structurePhotochemotherapyEpidermoid carcinomaCarcinoma Squamous CellbusinessFollow-Up StudiesEndoscopy
researchProduct

Radical Cystectomy - Often Too Late?

1987

From 1967 to 1985, 246 cystectomies for treatment of transitional cell carcinoma of the urinary bladder were performed. Perioperative mortality decreased from 15% in the early years to 0% in 1985. Preoperative radiotherapy was not given. Patients who underwent cystectomy immediately following the diagnosis of invasive bladder carcinoma had a significantly better prognosis than those having cystectomy after recurrence of a transurethrally resected invasive carcinoma in spite of identical G and T criteria. A total of 26 patients who were cystectomized because of tumor recurrence after definitive radiotherapy (salvage cystectomy) represented the group with the worst prognosis: they had a 5-yea…

medicine.medical_specialtyTime FactorsUrologymedicine.medical_treatmentUrologyCystectomyMethodsCarcinomamedicineAdjuvant therapyHumansSurvival rateCarcinoma Transitional CellUrinary bladderBladder cancerbusiness.industryPerioperativeMiddle AgedPrognosismedicine.diseaseSurgerymedicine.anatomical_structureTransitional cell carcinomaUrinary Bladder NeoplasmsNeoplasm Recurrence LocalbusinessEuropean Urology
researchProduct

Prevalence and Clinical Outcomes for Patients With ALK Gene Rearrangement in Europe: Preliminary Results from the European Thoracic Oncology Platform…

2012

ABSTRACT Background The prevalence of ALK gene rearrangement (ALK+) in European patients with non-small cell lung cancer (NSCLC) is unknown. The Lungscape project provides a platform to evaluate its expression and clinical significance in a large cohort of patients with resected NSCLC from 13 European sites in 11 countries. Methods Participating sites retrospectively identified cases of NSCLC with clinical demographic and outcome data, and available tissue for research according to predefined protocol criteria. Local ethical and regulatory approvals were adhered to. Clinical data were entered to a central, secure database. Accepted cases on the basis of completeness of clinical data were as…

medicine.medical_specialtyTissue microarrayClinical pathologyALK Gene Rearrangementbusiness.industryHematologymedicine.diseaseOncologyInternal medicineThoracic OncologyCohortmedicineAdenocarcinomaImmunohistochemistryClinical significancebusinessAnnals of Oncology
researchProduct

Imaging of hepatocellular carcinoma: a pilot international survey

2020

Purpose To perform an international survey on current practices in imaging-based surveillance, diagnosis, staging, and assessment of treatment response for HCC. Materials and methods Three themes were covered in this international survey: demographics of respondents and liver imaging expertise; imaging practices for screening, surveillance, diagnosis, staging, and assessment of treatment response for HCC; and diagnostic imaging systems used. Descriptive summaries were created. Results Of 151 respondents, 22.5% were from Asia, 6.0% from Europe, 19.9% from North America, 26.5% from South America, and 25.2% from Australasia; 57.0% respondents worked in academic and 34.4% in private or mixed se…

medicine.medical_specialtyTreatment responseCarcinoma HepatocellularDemographicsHepatocellular carcinomaUrologyContrast MediaComputed tomographyClinical practiceImaging030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineSurveys and QuestionnairesDiagnosismedicineMedical imagingHumansRadiology Nuclear Medicine and imagingMedical physicsUltrasonographyLiver imagingRadiological and Ultrasound Technologymedicine.diagnostic_testbusiness.industryLiver NeoplasmsGastroenterologyInternational surveymedicine.diseaseMagnetic Resonance ImagingStandardizationEurope030220 oncology & carcinogenesisHepatocellular carcinomaNorth AmericabusinessRegional differencesAbdominal Radiology
researchProduct

Das Plattenepithelkarzinom des Ösophagus – Stellenwert der Chirurgie im therapeutischen Konzept

2010

Squamous cell carcinomas of the oesophagus are a completely different entity from adenocarcinomas in regard to their aetiopathology, tumour biology, co-morbidity, operative risk, and prognosis. For superficial squamous cell carcinomas, the risk of a relevant lymph node metastatisation already exists from the mucosal infiltration level m3 onward, and thus oncological resection is indicated. Neoadjuvant radiochemotherapy is the international standard for locally advanced squamous cell carcinoma. The early-response should be determined. Non-responders must be identified early, and a salvage operation with a justifiable operative risk should be carried out. Due to its high complete response rat…

medicine.medical_specialtyTumor biologybusiness.industryHistopathological responsemedicine.medical_treatmentGastroenterologyMultimodal therapymedicine.diseaseSurgerySurgical morbidityRadiation therapyClinical trialmedicine.anatomical_structureOncologyEsophagectomyCarcinomamedicineCombined Modality TherapyIn patientOperative riskbusinessLymph nodePathologicalNeoadjuvant therapyTumorDiagnostik & Therapie
researchProduct